Precision Weight Management. Unmatched Value for Researchers.
🔬 Product Overview
Cagrilintide is a state-of-the-art, long-acting amylin analogue developed by Novo Nordisk. Functioning as a dual amylin and calcitonin receptor agonist, it introduces a novel mechanism of action for weight management, offering researchers a powerful and innovative tool for advancing metabolic health studies.
⸻
🚀 Key Benefits
• Dual Receptor Activation – Simultaneously targets amylin and calcitonin receptors to effectively regulate appetite, increase satiety, and support glucose metabolism.
• Clinically Proven Efficacy – Studies have shown dose-dependent, significant weight loss, with greater effects observed at higher doses.
• Enhanced Metabolic Health – Research indicates improved metabolic markers and substantial reductions in body weight.
• Cost-Effective for Long-Term Use – The 5mg vial offers an affordable option for extended research protocols, reducing cost per milligram compared to higher dosages.
• Free Injection Pen Included – Each order comes with a complimentary injection pen for accurate and convenient dosing.
⸻
🧪 Composition
• Active Ingredient: Cagrilintide
• Concentration: 5mg per vial
• Form: Lyophilized peptide powder
⸻
📦 Usage & Storage
• Intended Use: For research purposes only
• Storage Conditions: Store the lyophilized powder in a cool, dry place. Once reconstituted, refrigerate at 2–8°C and use within the prescribed study timeframe.
⸻
🛒 Now Available
Order your 5mg Cagrilintide today for just £200.00 — includes a free injection pen with every vial.
